Fueling Life

Fueling Life

Fueling Life is a podcast brought to you by — and all about — Diffusion Pharmaceuticals, an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen where it is needed most. This podcast will explore the science and ongoing studies of trans sodium crocetinate (TSC), our first-in-class, small molecule therapeutic that enhances the diffusion of oxygen to hypoxic tissues.

Folgen

  1. 15.10.2021

    Analyzing TSC’s Impact on Carbon Monoxide Diffusion Through the Lungs

    Diffusion’s Chief Medical Officer Dr. Chris Galloway provides an overview of the ILD-DLCO Trial, the third in a trio of Oxygenation Trials that will inform late-phase programs and clinical indications for lead drug candidate TSC.

    6 Min.

  2. 15.10.2021

    Evaluating the Effects of TSC on Maximal Oxygen Consumption

    Chief Medical Officer Dr. Chris Galloway previews Diffusion’s Altitude Trial, the second in a trio of Oxygenation Trials that will collectively inform late phase programs and the clinical development plan for lead drug candidate TSC.

    8 Min.

  3. 08.10.2021

    Exploring TSC’s Impact on Tissue-Level Changes in Oxygen

    Dr. Chris Galloway, Chief Medical Officer of Diffusion, explains the TCOM Trial design, top-line results, and the relevancy of this first of three Oxygenation Trials that together will inform late-phase programs and clinical indications for lead drug candidate TSC.

    8 Min.

  4. 02.09.2021

    The Science of Solving for Hypoxia

    In this episode, Diffusion Pharmaceuticals CEO Robert Cobuzzi, Jr., PhD discusses cellular oxygen deficiency, a condition known as hypoxia, outlines the company’s development plan, and highlights potential future applications for a small molecule therapeutic with a novel mechanism-of-action that enhances oxygen diffusion.

    13 Min.

  5. STAFFEL 1 – TRAILER

    Introducing Fueling Life: a Podcast from Diffusion Pharmaceuticals

    Hypoxia, a potentially fatal shortage of oxygen in body tissue, is a serious and potentially fatal medical condition. In Fueling Life, a new podcast from Diffusion Pharmaceuticals, we’ll discuss how and why hypoxia occurs, and explore how Diffusion Pharmaceuticals’ lead product candidate, trans sodium crocetinate (TSC), represents a novel, targeted treatment opportunity to enhance the standard-of-care for conditions associated with hypoxia.

    1 Min.

Trailer

Info

Fueling Life is a podcast brought to you by — and all about — Diffusion Pharmaceuticals, an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen where it is needed most. This podcast will explore the science and ongoing studies of trans sodium crocetinate (TSC), our first-in-class, small molecule therapeutic that enhances the diffusion of oxygen to hypoxic tissues.

Informationen

  • Erstellt von
    Fueling Life
  • Jahre aktiv
    2021
  • Folgen
    5
  • Bewertung
    Anstößig
  • Copyright
    © Fueling Life
  • Sendungswebsite
    Fueling Life